Efficacy and safety of combination therapy with vildagliptin and nateglinide in type 2 diabetes.
Phase of Trial: Phase II
Latest Information Update: 19 Jun 2013
At a glance
- Drugs Vildagliptin (Primary) ; Nateglinide
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 05 Oct 2012 Novartis Pharma KK added as study supporter
- 05 Oct 2012 Results presented at the 48th Annual Meeting of the European Association for the Study of Diabetes.
- 02 Jun 2012 Status changed from active, no longer recruiting to completed University Hospital Medical Information Network - Japan.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History